BioPlus Acquisition Total Debt vs. Cash And Equivalents
| BIOSWDelisted Stock | USD 0.14 0.00 0.00% |
For BioPlus Acquisition profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioPlus Acquisition to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioPlus Acquisition Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioPlus Acquisition's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioPlus Acquisition Corp over time as well as its relative position and ranking within its peers.
BioPlus |
BioPlus Acquisition Corp Cash And Equivalents vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioPlus Acquisition's current stock value. Our valuation model uses many indicators to compare BioPlus Acquisition value to that of its competitors to determine the firm's financial worth. BioPlus Acquisition Corp is the top company in total debt category among its peers. It is rated fourth in cash and equivalents category among its peers . The ratio of Total Debt to Cash And Equivalents for BioPlus Acquisition Corp is about 5,342 . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioPlus Acquisition by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.BioPlus Total Debt vs. Competition
BioPlus Acquisition Corp is the top company in total debt category among its peers. Total debt of Financials industry is currently estimated at about 8.27 Million. BioPlus Acquisition totals roughly 5 Million in total debt claiming about 60% of equities under Financials industry.
BioPlus Cash And Equivalents vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
BioPlus Acquisition |
| = | 5 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
BioPlus Acquisition |
| = | 936 |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
BioPlus Cash And Equivalents Comparison
BioPlus Acquisition is currently under evaluation in cash and equivalents category among its peers.
BioPlus Acquisition Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioPlus Acquisition, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioPlus Acquisition will eventually generate negative long term returns. The profitability progress is the general direction of BioPlus Acquisition's change in net profit over the period of time. It can combine multiple indicators of BioPlus Acquisition, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioPlus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York. Bioplus Acquisition operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.
BioPlus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioPlus Acquisition. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioPlus Acquisition position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioPlus Acquisition's important profitability drivers and their relationship over time.
Use BioPlus Acquisition in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioPlus Acquisition position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioPlus Acquisition will appreciate offsetting losses from the drop in the long position's value.BioPlus Acquisition Pair Trading
BioPlus Acquisition Corp Pair Trading Analysis
The ability to find closely correlated positions to BioPlus Acquisition could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioPlus Acquisition when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioPlus Acquisition - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioPlus Acquisition Corp to buy it.
The correlation of BioPlus Acquisition is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioPlus Acquisition moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioPlus Acquisition Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioPlus Acquisition can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioPlus Acquisition position
In addition to having BioPlus Acquisition in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |